Skip to main content
logo
NATCO Pharma Limited (BOM:524816)
India flag India · Delayed Price · Currency is INR
917.70
-15.15 (-1.62%)
At close: Aug 6, 2025

Patterson Companies Revenue

In the fiscal year ending March 31, 2025, NATCO Pharma had annual revenue of 44.30B INR with 10.68% growth. NATCO Pharma had revenue of 12.21B in the quarter ending March 31, 2025, with 13.95% growth.

Revenue
44.30B
Revenue Growth
+10.68%
P/S Ratio
3.67
Revenue / Employee
11.03M
Employees
4,016
Market Cap
162.60B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 202544.30B4.28B10.68%
Mar 31, 202440.02B12.94B47.76%
Mar 31, 202327.09B7.62B39.17%
Mar 31, 202219.46B-1.10B-5.35%
Mar 31, 202120.56B1.41B7.37%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Reliance Industries9,765.41B
HDFC Bank2,736.06B
Bharti Airtel1,839.41B
Tata Consultancy Services2,561.48B
ICICI Bank2,054.85B
State Bank of India3,429.39B
Infosys1,672.76B
Hindustan Unilever639.28B
Revenue Rankings

NATCO Pharma News

More News